Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.
暂无分享,去创建一个
Pratik Choudhary | J. Levy | P. Hindmarsh | N. Oliver | D. Matthews | P. Choudhary | N. Hill | David R Matthews | Jonathan C Levy | Nick S Oliver | Peter Hindmarsh | Nathan R Hill
[1] D. Matthews,et al. Time series analysis in endocrinology. , 1988, Acta paediatrica Scandinavica. Supplement.
[2] Michael Stumvoll,et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. , 2003, Diabetes.
[3] W. F. Taylor,et al. Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.
[4] J. Levy,et al. A method for assessing quality of control from glucose profiles , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[5] E. Kilpatrick,et al. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes , 2007, Diabetologia.
[6] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[7] C. McDonnell,et al. A novel approach to continuous glucose analysis utilizing glycemic variation. , 2005, Diabetes technology & therapeutics.
[8] D. Giugliano,et al. Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymerase , 2004, Journal of thrombosis and haemostasis : JTH.
[9] B. Zinman,et al. Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited , 2008, Diabetes.
[10] Antonio Ceriello,et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.
[11] J. Schlichtkrull,et al. [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS]. , 1964, Ugeskrift for laeger.
[12] G. Damante,et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. , 2001, American journal of physiology. Endocrinology and metabolism.
[13] Jean-Paul Cristol,et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.
[14] S. Heller,et al. Continuous glucose monitoring in patients with insulinoma , 2008, Clinical endocrinology.
[15] W. F. Taylor,et al. Day-to-day variation of continuously monitored glycaemia: A further measure of diabetic instability , 1972, Diabetologia.
[16] N. Clark,et al. Standards of Medical Care in Diabetes: Response to Power , 2006 .
[17] Joost B L Hoekstra,et al. Relationship between interstitial and blood glucose in type 1 diabetes patients: delay and the push-pull phenomenon revisited. , 2007, Diabetes technology & therapeutics.
[18] J. DeVries,et al. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes , 2007, Diabetologia.
[19] Robert Cuddihy,et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. , 2008, Diabetes technology & therapeutics.
[20] Wójcicki Jm,et al. J"-index. A new proposition of the assessment of current glucose control in diabetic patients. , 1995 .
[21] Weiqing Wang,et al. Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring , 2011, Medical science monitor : international medical journal of experimental and clinical research.
[22] J. Hans DeVries,et al. Glucose variability is associated with intensive care unit mortality* , 2010, Critical care medicine.
[23] P. Hindmarsh,et al. Validation of Continuous Glucose Monitoring in Children and Adolescents With Cystic Fibrosis , 2009, Diabetes Care.
[24] G. Paolisso,et al. Bariatric Surgery Reduces Oxidative Stress by Blunting 24-h Acute Glucose Fluctuations in Type 2 Diabetic Obese Patients , 2009, Diabetes Care.
[25] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[26] Michael Brownlee,et al. The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.
[27] D. Goldstein,et al. Glycated hemoglobin: methodologies and clinical applications. , 1986, Clinical chemistry.
[28] Daniel J Cox,et al. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. , 2003, Diabetes technology & therapeutics.
[29] A. Shapiro,et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. , 2004, Diabetes.
[30] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.